SCHEMBL4285509

SCHEMBL4285509

CC(=O)c1cccc(C=O)c1-c1ccccc1C=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.44
ERN1 O75460 4/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
LMNA P02545 1/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MYC P01106 1/20 0.39
TLR2 O60603 1/20 0.39
TLR1 Q15399 1/20 0.39
TLR6 Q9Y2C9 1/20 0.39
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
TRIM24 O15164 1/20 0.38
TRIM33 Q9UPN9 1/20 0.38
NPC1 O15118 1/20 0.36
POLB P06746 1/20 0.36
HNF4A P41235 1/20 0.36
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL547697 0.84 ALDH1A1 (0.51) ERN1KMT2AMEN1LMNATHRB
SCHEMBL4285512 0.84 MEN1 (0.44) PDK2ERN1KMT2AMEN1LMNA
SCHEMBL1484113 0.79 LMNA (0.52) ERN1KMT2AMEN1LMNATHRB
Benzene SCHEMBL28952313 0.77 LMNA (0.50) ERN1KMT2AMEN1LMNATHRB
SCHEMBL10415655 0.77 LMNA (0.50) ERN1KMT2AMEN1LMNATHRB
SCHEMBL10414731 0.77 LMNA (0.50) ERN1KMT2AMEN1LMNATHRB
SCHEMBL8120539 0.76 ERN1 (0.57) ERN1KMT2AMEN1LMNATHRB
SCHEMBL976750 0.75 LMNA (0.52) ERN1KMT2AMEN1LMNATHRB
SCHEMBL28215494 0.74 ERN1 (0.45) ERN1KMT2AMEN1LMNATHRB
Hydrochloric Acid SCHEMBL29912876 0.74 ERN1 (0.55) ERN1KMT2AMEN1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088444-A1 Substituted phenanthrene diketo acids and uses therefor BUOLAMWINI JOHN K 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090088444-A1 Substituted phenanthrene diketo acids and uses therefor WEE1, WEE2, HADHB PDK2 39/4885ERN1 1988/4885KMT2A 619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.